Blockchain-enabled genomic data sharing and analysis platform

July 2, 2017

Deoxyribonucleic acid, or DNA, is a molecule that encodes the blueprint of every living organism. DNA is a chain-like molecule of variable length made of four building blocks, commonly called letters (Figure 1). The four letters of DNA are adenine (A), thymine (T), cytosine (C), and guanine (G). Thus, while computers encode data using the binary system, the code of life uses four symbols.

Spotlight

Aurora Algae, Inc

Aurora Algae is the premier provider of algae-derived solutions for modern human health and nutrition. By combining cutting edge biotechnology with proprietary cultivation techniques, we are creating long-term, sustainable alternatives for the food, pharma, and supplement markets. We INVENT algae-based products to DISRUPT unsustainable markets & BENEFIT People and Planet.

OTHER WHITEPAPERS
news image

Synthetic Biology Biotechnology and AgTech

whitePaper | March 12, 2022

CRISPR, gene editing, biotech, precision agriculture and automation influencing the future of business, government, food, medicine, geopolitics and society

Read More
news image

Valorization of Starch to Biobased Materials

whitePaper | May 30, 2022

Many concerns are being expressed about the biodegradability, biocompatibility, and longterm viability of polymer-based substances. This prompted the quest for an alternative source of material that could be utilized for various purposes.

Read More
news image

Making the Promise of mRNA a Reality: OvercomingScale-Up Challenges

whitePaper | March 22, 2023

If scaling issues strike you as obvious or even boring, you should read “On Being the Right Size,” a 1926 essay by geneticist J.B.S. Haldane. It makes the case that a difference in scale—a seemingly simple matter—may demand subtle changes in form and function.

Read More
news image

U.S. NATIONAL SCIENCE FOUNDATION

whitePaper | August 21, 2022

The “Government Performance and Results Act” and the “GPRA Modernization Act of 2010 require federal agencies to develop strategic plans setting forth long-term goals and objectives. Guidance.

Read More
news image

Enabling the Future of Cell & Gene Therapies through Non Proprietary Patient-Owned Data Collection

whitePaper | March 16, 2021

Cell and gene therapies have emerged as a new treatment paradigm, and with them has come the potential to alter the course of many rare diseases. In many cases, there is an opportunity to correct the underlying dysfunction with a one-time administration of a therapy and provide either a functional cure or a substantial improvement in health outcomes. In other cases, long term symptom relief will be the primary therapeutic objective. Some of these indications may require more than one dose to achieve continued symptom relief and scientists and companies are working on technologies that will enable the use of a repeat dose.

Read More
news image

IoT To The Rescue For Biotech & Pharma Manufacturing

whitePaper | April 7, 2020

The Internet of Things (IoT) could not be timelier for biotech/pharma. With fierce cost pressures, the push for value-based outcomes, and the need for flexible manufacturing solutions, the IoT is the much-needed shot in the arm to bring about transformational change. Sensors, actuators, and devices (“things”) embedded in production equipment and networked through computer systems can generate an enormous amount of data. The data can be mined for insights and opportunities to drive production efficiency, automate monitoring and controlling functions, and enable flexible manufacturing systems.

Read More

Spotlight

Aurora Algae, Inc

Aurora Algae is the premier provider of algae-derived solutions for modern human health and nutrition. By combining cutting edge biotechnology with proprietary cultivation techniques, we are creating long-term, sustainable alternatives for the food, pharma, and supplement markets. We INVENT algae-based products to DISRUPT unsustainable markets & BENEFIT People and Planet.

Events